Achieving Patient Retention in Gene Therapy Follow Up
Mariah Baltezegar | Executive Director, Clinical Development | Rare Diseases | Syneos Health
Learn about the most effective strategies for optimizing patient retention throughout your gene therapy program (Phase 1-3, follow-up studies, registries). Discover new ways to better understand and navigate patient challenges first hand, including the logistical hurdles presented by moving from the initial “treatment” site/country (HCP) to potentially new follow-up sites/HCPs.
